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Abstract
Background: Nosocomial bacteremia is associated with a poor prognosis. Early adequate therapy
has been shown to improve outcome. Consequently, rapid detection of a beginning sepsis is
therefore of the utmost importance. This historical cohort study was designed to evaluate if
different patterns can be observed in either C-reactive protein (CRP) and white blood cell count
(WCC) between Gram positive bacteremia (GPB) vs. Gram negative bacteremia (GNB), and to
assess the potential benefit of serial measurements of both biomarkers in terms of early
antimicrobial therapy initiation.
Methods: A historical study (2003–2004) was conducted, including all adult intensive care unit
patients with a nosocomial bacteremia. CRP and WCC count measurements were recorded daily
from two days prior (d-2) until one day after onset of bacteremia (d+1). Delta (Δ) CRP and Δ WCC
levels from the level at d-2 onward were calculated.
Results: CRP levels and WCC counts were substantially higher in patients with GNB. Logistic
regression analysis demonstrated that GNB and Acute Physiology and Chronic Health Evaluation
(APACHE) II score were independently associated with a CRP increase of 5 mg/dL from d-2 to d+1,
and both were also independently associated with an increase of WCC levels from d-2 to d+1 of
5,000 × 103 cells/mm3.
Conclusion: Increased levels of CRP and WCC are suggestive for GNB, while almost unchanged
CRP and WCC levels are observed in patients with GPB. However, despite the different patterns
observed, antimicrobial treatment as such cannot be guided based on both biomarkers.
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Background
Nosocomial bloodstream infection (BSI) is a major com-
plication of intensive care unit (ICU) admission [1]. Phys-
iological features such as fever, tachycardia and tachypnea
have been proposed as indicators of sepsis [2,3]. These
findings may be sensitive, but are less specific in the diag-
nosis of systemic inflammation or infection [4,5]. In this
setting, C-reactive protein (CRP) and white blood cell
counts (WCC) have been shown to be more reliable mark-
ers [6-8]. Early initiation of appropriate antimicrobials is
a key to improve patients' survival [9]. Identification of
the isolated pathogen including antibiogram is available
at least 24-hrs after samples for blood cultures were per-
formed. Early recognition of even the first minor signs of
infection in case of a beginning bacteremia could there-
fore help to identify those patients who are more likely
infected with either Gram positive or Gram negative path-
ogens [3]. The primary aim of our study was to investigate
whether or not critically ill patients with nosocomial bac-
teremia caused by either Gram positive or Gram negative
bacteria, present different patterns in the evolution of
both biomarkers in order to facilitate decisions concern-
ing the initial choice of an empiric antibiotic regimen.
Methods
Setting
The study was conducted in the Ghent University Hospi-
tal, a 1062-bed tertiary teaching care centre in Belgium.
About 4100 patients are admitted to the 54-beds ICU
annually.
Study design
A historical observational cohort study of prospectively
collected data (2003–2004) was performed in which all
episodes of microbiological documented nosocomial bac-
teremia occurring in adult ICU patients (n = 174) were
included. All data (i.e. demographic, clinical, laboratory,
and physiological) were gathered by reviewing the charts
and the computerized hospital laboratory and adminis-
trative databases.
Serial measurements of CRP and WCC serum concentra-
tions were gathered, starting two days prior to onset of
bacteremia (d-2) onwards until one calendar day (which is
48-hrs) after onset of bacteremia (d+1) to record the
respective patterns of both biomarkers. To evaluate the
evolution over time, delta (Δ) CRP levels and Δ WCC lev-
els were calculated relative to the level at d-2. Patient char-
acteristics, laboratory variables, and antimicrobial
therapies were compared between episodes of Gram pos-
itive and Gram negative bacteremia. For analysis, only the
first episode of BSI was considered.
Definitions
Bacteremia was considered nosocomial when diagnosed ≥
48-hrs upon initial hospitalization. Onset of bacteremia
was defined as day 0 (d0), which corresponds to the day
the first positive blood culture was sampled. In case of
coagulase-negative Staphylococci, two positive blood cul-
tures yielding coagulase-negative Staphylococcus on sepa-
rate occasions within a 48-hrs period, and confirmation of
clinical significance of bacteremia by the attending inten-
sivist were required for diagnosis of bacteremia [10].
Blood cultures were routinely performed when the
patients' temperature was ≥38.5°C or when infection was
suspected on clinical grounds. Antimicrobial resistance
and susceptibility was determined according to the guide-
lines as recommended by the National Committee for
Clinical Laboratory Standards. Antibiotic therapy was
defined as 'adequate' when the drug administered had in-
vitro and clinical activity against the isolated strain and
when initiated within 48-hours after sampling the posi-
tive blood culture. Therapy was considered 'inadequate'
when there was no activity both, in-vitro and clinical
against the isolated strains or when no drug was adminis-
tered. Time to adequate antibiotics is defined as the time
delay between a blood culture that became positive and
the time adequate antibiotics were administered. In our
ICU a restricted antibiotic strategy is conscientious fol-
lowed [11]. The empiric antibiotic regimen administered
is based on the underlying pathology, patients' history,
local ecology, length of hospitalization, colonization sta-
tus, presumed inciting focus, and hemodynamic status of
the patient. Last-line antibiotics such as carbapenems and
glycopeptides are only given to those patients colonized
with multi-drug-resistant pathogens or those with a fulmi-
nated septic shock. Through mutual deliberation, differ-
ent specialists (i.e. intensivist, infectious disease specialist,
and microbiologist) daily verify whether narrowing the
antibiotic spectrum is possible. Further, prophylactic anti-
biotics are only given preoperatively. For those already
receiving antibiotic therapy, onset of BSI should be inter-
preted as a new outbreak of infection which on its turn
will provoke an inflammatory response expressed by CRP
and/or WCC changes in the blood. The source of bactere-
mia was determined by the attending intensivists and
microbiologists, based on the presumed portal of entry of
the isolated microorganism and by the clinical course.
Blood sampling for chemistry is routinely collected each
morning at 6 am. When multiple determinations were
performed during a day, the highest level of CRP and/or
WCC was taken into account.
Severity of illness was assessed by means of the Acute
Physiology and Chronic Health Evaluation (APACHE) II
score and determined daily as a surrogate marker of organ
dysfunction aiming to evaluate a patients' clinical evolu-
tion. Haemodynamic instability was defined as depend-BMC Infectious Diseases 2007, 7:106 http://www.biomedcentral.com/1471-2334/7/106
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ence of vasoactive or inotropic therapy, acute renal failure
as the need for haemodialysis, and respiratory failure as
ventilation dependency during ICU stay [12-14].
Statistical analysis
Variables are described as mean ± standard deviation (SD)
and median (interquartile range). The Mann-Whitney U
test and the Chi-square test were used as appropriate. A
multivariable logistic regression was performed, including
all variables having a P-value <0.10 in univariate analysis
or with plausible relationship with both biomarkers to
assess the impact of these determinants on the dynamics
of CRP and WCC levels, respectively. Goodness-of-fit was
tested by means of the Hosmer-Lemeshow statistic tech-
nique. Significance was accepted for a two-tailed P-value
<0.05. For analysis, SPSS 12.0 (SPSS Inc., Chicago, IL,
USA) software package was used.
The present study was approved by the Ethics Committee
of the Ghent University Hospital (registration number:
B67020072006).
Results
During the study period we recorded a total of 198 epi-
sodes of nosocomial BSI. Ninety-three episodes were
excluded because of missing laboratory variables (n = 29),
when polymicrobial (n = 40), or when fungal (n = 20) or
anaerobic pathogens involved (n = 4). For 105 episodes
(occurring in 84 patients) all data were available. Of these
episodes, 42 were classified as Gram positive bacteremia
Flow chart of exclusion criteria of episodes of nosocomial bacteremia (2003–2004) Figure 1
Flow chart of exclusion criteria of episodes of nosocomial bacteremia (2003–2004). ICU, intensive care unit; BSI, 
bloodstream infection; GPB, Gram positive bacteremia; GNB, Gram negative bacteremia.
ICU patients with
a diagnosed BSI
n = 110
Total number of episodes
of  nosocomial BSI
n = 198
BSI episodes caused by
Gram positive and Gram
negative pathogens
n = 174
Candida spp. n = 20
Missing data n = 9
Anaerobics n = 4
Missing data n = 1
Monomicrobial episodes
of GPB and GNB
n = 134
Polymicrobial episodes
n = 40
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of GPB and GNB without
missing data
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Episodes with
missing data
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n = 84
Episodes of GPB
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(GPB) (43%) (occurring in 36 patients) and 63 as Gram
negative bacteremia (GNB) (57%) (occurring in 48
patients) (Figure 1). Bacterial strains resistant to first line
antibiotics were more prevalent encountered in GPB (P <
0.001).
Patients with GPB and patients with GNB had comparable
age and sex distribution, organ failure during ICU stay,
and severity of illness on ICU admission (Table 1). Over-
all, 90.5% vs. 90.5% of episodes were treated adequately
(P = 0.999), however, there was a significant delay to ini-
tiation of adequate therapy in patients with Gram positive
aetiology of bacteremia; 52.4% in patients with GPB com-
pared to 76.6% in patients with GNB within 24-hrs after
onset of bacteremia (P = 0.010), and 70.7% compared to
89.6% within 48-hrs (P = 0.037). Similarly, mean time
delay to adequate therapy was 1.6 ± 1.6 days vs. 0.6 ± 0.8
days (P < 0.001) in GPB and GNB, respectively. Microbio-
logical causes of BSI episodes are listed in Table 2.
Serum CRP concentrations were higher in patients with
GNB than with GPB from d0  on. Moreover, in GNB
patients these levels showed a steady and significant
increase from d-2 onward with a peak concentration at d1
(P = 0.009), whereas in patients with GPB, these levels
showed only a smooth increase (Figure 2). Evaluation of
serial WCC levels showed comparable results (Figure 3).
Analysis of the time course, as expressed by Δ CRPd-2 to d+1
and Δ WCCd-2 to d+1 levels, showed that median Δ CRPd-2 to
d+1 levels for GPB and GNB were 3.1 mg/dL (-2.4 mg/dL-
7.8 mg/dL) vs. 6.2 mg/dL (0.9 mg/dL-14.2 mg/dL) (P =
0.025), and median Δ WCCd-2 to d+1 levels were 180 × 103
cells/mm3  (-2,100 × 103  cells/mm3-3,500 × 103  cells/
mm3) vs. 1,900 × 103 cells/mm3 (-1,500 × 103 cells/mm3-
7,100 × 103 cells/mm3) (P  = 0.171). We also verified
whether an increase of CRP levels from d-2 to d+1 of 5 mg/
dL, and whether an increase of WCC levels from d-2 to d+1
of 5,000 × 103 cells/mm3 could differentiate between GPB
and GNB. Both cutt-offs were exceeded in 9/36 (25.0%)
and 8/36 (22.2%) of patients with GPB, compared to 35/
48 (72.9%) and 36/48 (75.0%) in patients with GNB (P =
0.011 and P = 0.035, respectively).
Multivariate logistic regression analysis identified GNB
(OR,5.06; 95% CI,1.52–16.91; P = 0.008) to be independ-
ently associated with a CRP level increase of 5 mg/dL from
d-2 to d+1, whereas APACHE II score was not (OR,0.87;
95% CI,0.79–0.96; P  = 0.006) (Goodness-of-fit; chi-
square,2.46; df,8; P = 0.963). Gram negative aetiology of
bacteremia (OR,3.31; 95% CI,0.96–11.41; P = 0.040) and
Table 1: Patient baseline characteristics. SD, standard deviation; APACHE, Acute Physiology and Chronic Health Evaluation; ICU, 
intensive care unit; LOS, length of stay
Characteristic Episodes of Gram-positive 
bacteremia (n = 42)
Episodes of Gram-negative 
bacteremia (n = 63)
P
Age, years, mean (SD) 55.6 ± 19.5 58.3 ± 15.2 0.905
Female, No (%) 15 (41.7) 16 (33.3) 0.497
APACHE II, mean (SD) 19.1 ± 6.7 20.5 ± 7.8 0.400
Comorbidity
Liver disease, No (%) 1 (2.8) 0 (0.0) 0.429
Antibiotic therapy
Adequate therapy ≤24-hrs, No (%) 22 (52.4) 48 (76.6) 0.010
Adequate therapy ≤48-hrs, No (%) 30 (70.7) 56 (89.6) 0.037
Adequate therapy, No (%) 38 (90.5) 57 (90.5) 0.999
Delay in the start of adequate therapy, mean (SD) 1.6 ± 1.6 0.6 ± 0.8 <0.001
Outcome
ICU LOS, median (range) 16.5 (5.5–31.0) 19.5 (3.0–30.3) 0.726
ICU LOS before onset of bacteremia, median (range) 9.0 (1.3–24.0) 8.0 (2.3–17.8) 0.544
In-hospital mortality, No (%) 13 (36.1) 22 (45.8) 0.503
Table 2: Microbiological causes of nosocomial Gram positive and 
Gram negative bacteremia
Organism n Number of anti-
biotic suscepti-
ble bacteria n(%)
Gram-positive bacteria 42 9 (21.4)
Staphylococcus spp. 34
Staphylococcus aureus 11 1 (2.4)
Coagulase-negative staphylococci 23 0 (0.0)
Streptococci/Enterococci 8 8 (19.0)
Gram-negative bacteria 63 53 (84.1)
Enterobacter spp. 20 13 (20.6)
Pseudomonas aeruginosa 16 15 (23.8)
Klebsiella spp. 8 8 (12.7)
Escherichia coli 6 6 (9.5)
Proteus spp. 5 5 (7.9)
Serratia marcescens 3 3 (4.8)
Acitenobacter 2 2 (3.2)
Stenotrophomonas maltophilia 1 0 (0.0)
Morganella morganii 1 1 (1.6)
Flavo bacterium 1 0 (0.0)BMC Infectious Diseases 2007, 7:106 http://www.biomedcentral.com/1471-2334/7/106
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APACHE II score (OR,1.10; 95% CI,1.00–1.20; P = 0.044)
(Goodness-of-fit; chi-square,6.45; df,8; P = 0.587) were
both independently associated with an increase of WCC
levels from d-2 to d+1 of 5,000 × 103 cells/mm3. Focuses of
infection as well as appropriateness of antibiotics were
not shown to be independent determinants in the dynam-
ics of both biomarkers (all P > 0.05).
Discussion
Early initiation of adequate antimicrobial therapy is criti-
cal to ensure good outcome in severe infection [15-19].
Therefore, early recognition and accurate diagnosis of bac-
teremia is highly desirable, and appropriate antibiotics
should not be delayed until blood cultures identify the
offending pathogen [20]. However, increasing antimicro-
bial resistance and concerns about antibiotic exposure
driving selection of multidrug-resistant strains have com-
plicated both empiric antibiotic choices and clinical deci-
sions whether to start antibiotics. The present study
investigated whether Gram positive vs. Gram negative
pathogens have different patterns in CRP and WCC count
levels in order to help physicians in their daily clinical
judgment.
Previous studies comparing groups of patients who
received antibiotics because of documented vs. suspected
infection, already evaluated serum concentrations of CRP
and/or WCC counts in the diagnosis of infection [6,21-
23]. However, most of these studies used the American
College of Chest Physicians/Society of Critical Care Med-
icine Consensus Conference guidelines to define the pres-
ence or absence of sepsis [3,24]. Because these criteria are
consensually considered to have high sensitivity and low
specificity, we therefore selected a very homogeneous
group of patients with unequivocal bacterial sepsis.
Although our cohort already had high baseline CRP and
WCC count serum concentrations, some differential
observation could be made after the onset of bacteremia
with respect to both biomarkers. Patients with GPB dem-
onstrated lower CRP and WCC levels at onset of bactere-
mia, which remained almost stable during the four study
days. On the other hand, CRP and WCC levels at d+1, as
well as the absolute increase between d-2 and d+1were sig-
nificantly higher in patients with GNB. In both groups
(patients with GPB vs. GNB) peak concentrations of CRP
and WCC levels were observed one day following onset of
bacteremia (P = 0.009, and P = 0.008), respectively. In
accordance to earlier reports, by combining CRP and
WCC measurements we could not further improve specif-
Dynamics of white blood cell count serum concentrations in  ICU patients with nosocomial bacteremia involving either  Gram positive vs. Gram negative bacteria Figure 3
Dynamics of white blood cell count serum concentrations in 
ICU patients with nosocomial bacteremia involving either 
Gram positive vs. Gram negative bacteria.
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Dynamics of C-reactive protein serum concentrations in ICU 
patients with nosocomial bacteremia involving either Gram 
positive vs. Gram negative bacteria.
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icity for the diagnosis of bacteremia [6,25]. Using Δ CRP
and Δ WCC levels in order to evaluate their respective evo-
lution over time, multivariate analysis showed that Gram
negative aetiology of bacteremia was independently asso-
ciated with (i) an increase of CRP levels of 5 mg/dL, and
(ii) an increase of WCC of 5,000 × 103 cells/mm3 from two
days prior until one day after onset of bacteremia, respec-
tively. Remarkably, APACHE II score was, however, not
independently associated with the first scenario (CRP
increase), whereas it was independently associated with
the latter (WCC increase). In both models, appropriate-
ness of antibiotic therapy as well as focus of infection had
no association with neither CRP nor with WCC.
Attributable mortality rates up to 45% have been reported
in case of an inadequate choice of empirical therapy in
patients with nosocomial bacteremia [26]. Because micro-
biological results generally only are available 48-hrs after
blood cultures were obtained, and adjustment of inade-
quate therapy at this time poorly influences outcome,
there is need for clinical or biochemical parameters to
warn the clinician of an inadequate empiric choice at an
earlier stage in the course [15,27]. In our study cohort,
episodes of nosocomial BSI due to Gram positive bacteria
received similar rates of adequate antibiotics compared
with episodes of GNB; however, a substantial delay in the
start was observed (P  < 0.001). We noted a high rate
(47.6%) of inadequate therapy within the first 24-hrs fol-
lowing onset of infection among episodes of GPB. This
figure illustrates that particularly in this subgroup; consid-
erable benefit could be achieved with respect to this time
delay. Taken the relationship between the delay in starting
adequate antimicrobial therapy and clinical outcome, a
role for serial measurements of WCC and especially CRP
serum concentrations in the early detection, as well as for
follow up of bacteremia among critically ill patients may
be presumed. Because in patients with GPB the highest
rates of inadequate treatment are recorded, an increase of
both CRP and WCC levels could be expected. However,
this was not confirmed in our data. No significant differ-
ences were found in CRP and WCC levels according to the
appropriateness of empirical antibiotic treatment.
Although an adequate empirical antibiotic regimen is ini-
tiated, an increase of CRP and/or WCC levels is frequently
observed over the next 24-hrs or even 48-hrs. Addition-
ally, other events such as recent surgery, inflammatory
insult, pancreatitis and trauma may cause fluctuations in
CRP levels, respectively. Further, in the GPB-group, coag-
ulase-negative Staphylococci were the most frequently
isolated pathogens. In addition to the above, this may
also explain the high observed rate of inadequate choice
of empirical antibiotics. Though, since these pathogens
are considered to be less virulent compared to other Gram
positive strains such as Staphylococcus spp., serial measure-
ments of CRP and WCC seem to be less relevant for this
purpose.
The present study only investigated the dynamics of two
variables (CRP and WCC) in their ability to differentiate
between bacteremia caused by Gram positive vs. Gram
negative pathogens. The short period of observation (4
days, respectively) includes another limitation of this
study. Taken into account a longer period could have
resulted in additional information (e.g. the amplitude of
CRP and/or WCC levels could have been observed to be
more pronounced before onset of bacteremia), though in
an ICU setting, many other factors associated with
increased CRP and/or WCC levels, however, not of infec-
tious origin, are frequently observed. We used the
APACHE II score as a surrogate marker of organ dysfunc-
tion; however, other scores aimed to assess severity of ill-
ness could have resulted in other conclusions. Also, we
could not provide data with regard to previous antibiotic
therapy in this cohort which might have biased our
results. Because our findings are based on a single centre
study, one should be careful when interpreting or extrap-
olating these data. Next, other physical or laboratory crite-
ria such as fever, hypothermia, tachycardia, tachypnea,
inflammatory mediators (e.g. interleukine-6, tumor
necrosis factor-α) were not evaluated and might be more
straightforward in this assessment. Lastly, as this study
was conducted retrospectively, it is recommended to
repeat this study with a prospective design. Nonetheless,
this study is the first to elaborate on the dynamics of CRP
and WCC levels in adult ICU patients with GPB and GNB.
Conclusion
In conclusion, surveillance of bacteremia in the ICU is
crucial in detecting major changes in aetiology such as the
increasing incidence of GPB. Our findings suggest that
obvious different patterns are observed in patients with
nosocomial GPB vs. GNB, with respect to both biomark-
ers studied. However, their use is less relevant in guiding
antibiotic therapy.
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